Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Circulation
; 139(3): 416-417, 2019 01 15.
Article
in En
| MEDLINE
| ID: mdl-30640544
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
Heart Failure
Limits:
Humans
Language:
En
Journal:
Circulation
Year:
2019
Document type:
Article